Commonwealth Equity Services, LLC Mustang Bio, Inc. Transaction History

Commonwealth Equity Services, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$0.35 - $0.72 $1,981 - $4,076	5,662 Added 11.83%	53,516 $19,000
Q4 2022 Feb 07, 2023	BUY	$0.32 - $8.27 $4,669 - $120,675	14,592 Added 43.87%	47,854 $18,000
Q3 2022 Nov 14, 2022	BUY	$0.46 - $7.2 $6,404 - $100,238	13,922 Added 71.99%	33,262 $15,000
Q2 2022 Jul 19, 2022	BUY	$0.58 - $1.13 $11,217 - $21,854	19,340 New	19,340 $11,000
Q1 2022 May 04, 2022	SELL	$0.73 - $1.81 $7,683 - $19,050	-10,525 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$2.7 - $3.81 $28,417 - $40,100	10,525 New	10,525 $34,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $27.4M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.